JCINEUTRAL

P/E Ratio

25.0x

Updated 200h ago

Sector Performance

51th percentile

JCI

25.0x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The current P/E ratio of 25.0x means investors are paying $25.00 for every $1.00 of the company's annual earnings — a higher P/E often indicates higher expected growth or a premium valuation.

This sits slightly above the sector median of 24.1x, placing it at the 53rd percentile among sector peers, meaning it is roughly in the middle of the pack. The trend has been stable over the last eight quarters, with the most recent three values of 25.0x, 24.6x, and 25.9x showing little fluctuation; the quarter-over-quarter change was +1.5%, while the year-over-year change is not available. The combination of a near-median P/E with a stable trend suggests limited valuation risk and no imminent re-rating, offering neither a clear opportunity nor a heightened risk. This metric supports the overall NEUTRAL verdict because the valuation is neither cheap enough to be a bargain nor expensive enough to warrant caution, aligning with a balanced outlook.

Frequently Asked Questions

What does the P/E Ratio tell investors about JCI?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are JCI's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master JCI's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full JCI research report

Free account — no credit card

JCI

25.0x

Sector Median

24.7x

Sector Avg

36.0x

How JCI's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.